Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients

Sponsor
Mayo Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03770598
Collaborator
(none)
200
1
2
47.1
4.2

Study Details

Study Description

Brief Summary

Researchers are trying to see if proactive identification and team based individualized care of cancer patients having emotional difficulties can improve quality of life relative to treatment as usual. Also, to see if proactive approaches to maintain wellness can prevent grief among breast cancer patients, experiencing no emotional difficulties relative to treatment as usual.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Standard of Care Distressed in study Arm Distressed
  • Behavioral: Psycho-Education
  • Behavioral: Team Based Care
  • Behavioral: Standard of Care Non-Distressed
N/A

Detailed Description

Consented subjects will be randomized into two separate groups. Groups will be distressed and non-distressed subjects. Each group will be randomized into either intervention education training or standard of care. Both groups will be asked to fill out questionnaires during the duration of the study. Subjects will be remain in the study for up to one year.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Non-Distressed patients will be randomized to receive intervention or standard of care. Distressed patients will be randomized to receive intervention or standard of careNon-Distressed patients will be randomized to receive intervention or standard of care. Distressed patients will be randomized to receive intervention or standard of care
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients
Actual Study Start Date :
Nov 28, 2018
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Distressed

Study participants who do indicate distress or who do meet criteria for depression or anxiety will be randomized to receive either treatment as usual (referral to Psychiatry or Psychology for evaluation and further treatment) or team based care model.

Behavioral: Standard of Care Distressed in study Arm Distressed
Social worker evaluation and possible referral to Psychiatry/Psychology for evaluation and further treatment.

Behavioral: Team Based Care
Psychiatrist, Oncologist, clinical social worker, study coordinator

Active Comparator: Non-Distressed

Study participants who do not indicate distress or who do not meet criteria for depression or anxiety will be randomize to monitoring only or to receive psycho-education regarding subjects that when used can promote wellness.

Behavioral: Psycho-Education
Mindfulness based stress reduction class, yoga and education material

Behavioral: Standard of Care Non-Distressed
No psycho-education about wellness promotion or health. These patients will be monitored only.

Outcome Measures

Primary Outcome Measures

  1. Change in Wellness [baseline, 6 months]

    Subject wellness scores based on Short Warwick-Edinburgh Mental-Wellbeing Scale. This is a 7 item scale monitoring of mental wellbeing in subjects. Responses are based on a 1 to 5 item scale with 1 = None of the time, 2 = Rarely, 3 = Some of the Time, 4 = Often, 5 = All of the Time.

Secondary Outcome Measures

  1. Improvement in depression compared to baseline [one year]

    measured by using PHQ-8 (Patient Health Questionnaire); this is an 8 item scale. Scores of 5 or less are considered no depression, 5-10, mild depression, 11-15, moderate depression, 16-20 moderately severe and more than 20 is considered severe depression.

  2. Improvement in anxiety compared to baseline [One Year]

    Will be measured by GAD-7 (Generalized Anxiety Disorder 7-item Scale). Its a 7 item scale. Cut points of 5, 10, 15 represent mild, moderate and severe levels of anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of breast cancer within last three years

  • Able to communicate in English or with the help of an interpreter.

  • Access to a device with internet connection

Exclusion Criteria:
  • Breast cancer patients who are considered for hospice or expected survival of less than six months.

  • Presence of active suicidal ideations.

  • Presence of active psychosis.

  • Presence of dementia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Jacksonville Florida United States 32081

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Shehzad K Niazi, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Shehzad K. Niazi, Prinicpal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT03770598
Other Study ID Numbers:
  • 18-000718
First Posted:
Dec 10, 2018
Last Update Posted:
May 26, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shehzad K. Niazi, Prinicpal Investigator, Mayo Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 26, 2022